Published in J Med Microbiol on January 06, 2011
Evaluation of the FilmArray Blood Culture Identification Panel: Results of a Multicenter Controlled Trial. J Clin Microbiol (2016) 1.02
Use of 16S rRNA gene for identification of a broad range of clinically relevant bacterial pathogens. PLoS One (2015) 0.94
Raoultella ornithinolytica: An unusual pathogen for prosthetic joint infection. IDCases (2016) 0.81
Use of cellulolytic marine bacteria for enzymatic pretreatment in microalgal biogas production. Appl Environ Microbiol (2014) 0.81
Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother (2005) 3.87
Genetic dissection of complex traits with chromosome substitution strains of mice. Science (2004) 3.57
Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis (2003) 3.20
Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antimicrob Agents Chemother (2002) 2.86
Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob Agents Chemother (2008) 2.70
Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia. Antimicrob Agents Chemother (2007) 2.42
Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features. Clin Infect Dis (2009) 2.26
A survey of community-associated methicillin-resistant Staphylococcus aureus in Korea. J Antimicrob Chemother (2007) 2.22
Effect of routine sterile gloving on contamination rates in blood culture: a cluster randomized trial. Ann Intern Med (2011) 2.21
Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase-producing Klebsiella pneumoniae. Antimicrob Agents Chemother (2004) 2.20
Optimal dose of intra-articular corticosteroids for adhesive capsulitis: a randomized, triple-blind, placebo-controlled trial. Am J Sports Med (2013) 2.12
Bilateral same-day intravitreal injections using a single vial and molecular bacterial screening for safety surveillance. Retina (2012) 2.09
Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol (2004) 2.05
Use of reduced-dose periarticular injection for pain management in simultaneous bilateral total knee arthroplasty. J Arthroplasty (2012) 2.03
Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy. Antimicrob Agents Chemother (2004) 2.02
Outbreak of Mycobacterium massiliense infection associated with intramuscular injections. J Clin Microbiol (2007) 1.96
Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem. Clin Infect Dis (2009) 1.85
oqxAB encoding a multidrug efflux pump in human clinical isolates of Enterobacteriaceae. Antimicrob Agents Chemother (2009) 1.77
The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial. Clin Infect Dis (2012) 1.76
Diagnostic usefulness of a T-cell-based assay for extrapulmonary tuberculosis in immunocompromised patients. Am J Med (2009) 1.71
Dissemination of SHV-12 and CTX-M-type extended-spectrum beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea. J Antimicrob Chemother (2005) 1.60
Spontaneous cryptococcal peritonitis in patients with liver cirrhosis. Am J Med (2006) 1.51
The activation of ERK1/2 via a tyrosine kinase pathway attenuates trail-induced apoptosis in HeLa cells. Cancer Invest (2005) 1.44
In vitro activities of 28 antimicrobial agents against Staphylococcus aureus isolates from tertiary-care hospitals in Korea: a nationwide survey. Antimicrob Agents Chemother (2004) 1.43
Use of MALDI-TOF MS technique for rapid identification of bacteria from positive blood cultures. Indian J Med Microbiol (2014) 1.42
A comparative study of pyogenic and tuberculous spondylodiscitis. Spine (Phila Pa 1976) (2010) 1.41
HBsAg seroclearance in chronic hepatitis B: implications for hepatocellular carcinoma. J Clin Gastroenterol (2011) 1.40
Is cefazolin inferior to nafcillin for treatment of methicillin-susceptible Staphylococcus aureus bacteremia? Antimicrob Agents Chemother (2011) 1.40
Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci. Clin Infect Dis (2003) 1.39
Change in antibiotic resistance of Helicobacter pylori strains and the effect of A2143G point mutation of 23S rRNA on the eradication of H. pylori in a single center of Korea. J Clin Gastroenterol (2010) 1.36
Comparison of the MicroScan, VITEK 2, and Crystal GP with 16S rRNA sequencing and MicroSeq 500 v2.0 analysis for coagulase-negative Staphylococci. BMC Microbiol (2008) 1.34
Prevalence of the VNIc genotype of Cryptococcus neoformans in non-HIV-associated cryptococcosis in the Republic of Korea. FEMS Yeast Res (2010) 1.32
Multiplex enzyme assay for galactosemia using ultraperformance liquid chromatography-tandem mass spectrometry. Clin Chem (2010) 1.31
Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer. BMC Cancer (2012) 1.31
Community-acquired versus nosocomial Klebsiella pneumoniae bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance. J Korean Med Sci (2006) 1.31
Detection and biovar discrimination of Ureaplasma urealyticum by real-time PCR. Mol Cell Probes (2005) 1.30
Comparison of four current 25-hydroxyvitamin D assays. Clin Biochem (2012) 1.28
Proteolytic cleavage of extracellular secreted {alpha}-synuclein via matrix metalloproteinases. J Biol Chem (2005) 1.25
Amebic liver abscess in HIV-infected patients, Republic of Korea. Emerg Infect Dis (2007) 1.25
Clinical significance of intratumoral HER2 heterogeneity in gastric cancer. Eur J Cancer (2012) 1.19
Risk factors for antimicrobial resistance and influence of resistance on mortality in patients with bloodstream infection caused by Pseudomonas aeruginosa. Microb Drug Resist (2005) 1.18
Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother (2004) 1.16
Tuberculosis manifested by immune reconstitution inflammatory syndrome during HAART. AIDS (2007) 1.16
A case of necrotizing pancreatitis subsequent to transcatheter arterial chemoembolization in a patient with hepatocellular carcinoma. Clin Mol Hepatol (2012) 1.16
AICAR potentiates ROS production induced by chronic high glucose: roles of AMPK in pancreatic beta-cell apoptosis. Cell Signal (2006) 1.16
Differential identification of Mycobacterium tuberculosis complex and nontuberculous mycobacteria by duplex PCR assay using the RNA polymerase gene (rpoB). J Clin Microbiol (2004) 1.16
Microbiologically and clinically diagnosed vertebral osteomyelitis: impact of prior antibiotic exposure. Antimicrob Agents Chemother (2012) 1.15
Nationwide surveillance for Staphylococcus aureus with reduced susceptibility to vancomycin in Korea. J Clin Microbiol (2003) 1.15
Simultaneous determination of first-line anti-tuberculosis drugs and their major metabolic ratios by liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom (2007) 1.15
Genetic factors influencing severe atazanavir-associated hyperbilirubinemia in a population with low UDP-glucuronosyltransferase 1A1*28 allele frequency. Clin Infect Dis (2010) 1.14
BCG osteomyelitis caused by the BCG Tokyo strain and confirmed by molecular method. Vaccine (2008) 1.14
Clinical outcome of bacteremic spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Korean J Intern Med (2004) 1.14
A case of esophageal intramural pseudodiverticulosis. Gut Liver (2011) 1.11
Diagnosis of central nervous system tuberculosis by T-cell-based assays on peripheral blood and cerebrospinal fluid mononuclear cells. Clin Vaccine Immunol (2008) 1.11
The interval between initiation of anti-tuberculosis treatment in patients with culture-positive pulmonary tuberculosis and receipt of drug-susceptibility test results. J Korean Med Sci (2007) 1.11
Acute hemorrhagic conjunctivitis caused by coxsackievirus A24 variant, South Korea, 2002. Emerg Infect Dis (2003) 1.09
Treatment failure due to emergence of resistance to carbapenem during therapy for Shewanella algae bacteremia. J Clin Microbiol (2006) 1.09
Primary anti-D immunization by DEL red blood cells. Korean J Lab Med (2009) 1.09
[Standardization of terminology in laboratory medicine I]. Korean J Lab Med (2007) 1.08
Method for simultaneous analysis of nine second-line anti-tuberculosis drugs using UPLC-MS/MS. J Antimicrob Chemother (2013) 1.08
Late presentation of HIV disease and its associated factors among newly diagnosed patients before and after abolition of a government policy of mass mandatory screening. J Infect (2011) 1.07
Outcomes of Hickman catheter salvage in febrile neutropenic cancer patients with Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol (2003) 1.07
Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: a retrospective matched case-control study. BMC Infect Dis (2009) 1.06
Normative Temporal Values of CRP and ESR in Unilateral and Staged Bilateral TKA. Clin Orthop Relat Res (2008) 1.05
Activation of PERK signaling attenuates Abeta-mediated ER stress. PLoS One (2010) 1.05
Association between blood pressure variability and inflammatory marker in hypertensive patients. Circ J (2008) 1.05
Castleman disease presenting with jaundice: a case with the multicentric hyaline vascular variant. Korean J Intern Med (2007) 1.04
Pyogenic vertebral osteomyelitis: identification of microorganism and laboratory markers used to predict clinical outcome. Eur Spine J (2009) 1.04
Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea. Emerg Infect Dis (2015) 1.04
Analysis of multiple single nucleotide polymorphisms of candidate genes related to coronary heart disease susceptibility by using support vector machines. Clin Chem Lab Med (2003) 1.03
Dyrk1A phosphorylates alpha-synuclein and enhances intracellular inclusion formation. J Biol Chem (2006) 1.03
Effect of SOCl2 treatment on electrical and mechanical properties of single-wall carbon nanotube networks. J Am Chem Soc (2005) 1.03
Performance evaluation of the OraQuick hepatitis C virus rapid antibody test. Ann Lab Med (2013) 1.03
Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome. Clin Infect Dis (2004) 1.02
Simultaneous detection of Mycobacterium tuberculosis complex and nontuberculous mycobacteria in respiratory specimens. Tuberculosis (Edinb) (2013) 1.02
Decreased serum vitamin D in idiopathic benign paroxysmal positional vertigo. J Neurol (2012) 1.01
Association between the methicillin resistance of clinical isolates of Staphylococcus aureus, their staphylococcal cassette chromosome mec (SCCmec) subtype classification, and their toxin gene profiles. Diagn Microbiol Infect Dis (2006) 1.01
Phase variation of biofilm formation in Staphylococcus aureus by IS 256 insertion and its impact on the capacity adhering to polyurethane surface. J Korean Med Sci (2004) 1.00